63 related articles for article (PubMed ID: 37478616)
21. The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women.
Braga A; Lopes R; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; de Sousa CB; Leal E; Yela D; Uberti E; Madi JM; Viggiano M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
Gynecol Oncol; 2023 Sep; 176():130-138. PubMed ID: 37524011
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma.
Gorczyński A; Miszewski K; Gager Y; Koch S; Pötschke J; Ugrinovski D; Gabert J; Pospieszyńska A; Wydra D; Duchnowska R; Szymanowski B; Cierniak S; Kruecken I; Neumann K; Mirkov K; Biernat W; Czapiewski P
Cancer Biomark; 2023; 38(1):17-26. PubMed ID: 37522200
[TBL] [Abstract][Full Text] [Related]
23. Validation of Dual-Color Dual In Situ Hybridization for HER2/neu Gene in Breast Cancer.
Rathi A; Sahay A; Shet TM; Patil A; Desai SB
Arch Pathol Lab Med; 2024 Apr; 148(4):453-460. PubMed ID: 37490416
[TBL] [Abstract][Full Text] [Related]
24. Identification and protection of early cardiotoxicity in acute myeloid leukemia patients undergoing transplantation.
Jiang T; Wang M; Zhang N; Dong Q; Tang X
Hematology; 2023 Dec; 28(1):2239569. PubMed ID: 37489927
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study.
Tashiro R; Kawazoe H; Mamishin K; Seto K; Udagawa R; Saito Y; Hashimoto H; Shimoi T; Yonemori K; Yonemura M; Terakado H; Nishimura T; Kawasaki T; Furukawa T; Nakamura T
Sci Rep; 2023 Jul; 13(1):11962. PubMed ID: 37488223
[TBL] [Abstract][Full Text] [Related]
26. Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258.
Lee SS; Weil CR; Boyd LR; DeCesaris C; Gaffney D; Suneja G
Int J Gynecol Cancer; 2023 Sep; 33(9):1408-1418. PubMed ID: 37487661
[TBL] [Abstract][Full Text] [Related]
27. p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer.
de Kort WWB; de Ruiter EJ; Haakma WE; Driehuis E; Devriese LA; van Es RJJ; Willems SM
Head Neck Pathol; 2023 Sep; 17(3):697-707. PubMed ID: 37486536
[TBL] [Abstract][Full Text] [Related]
28. Retraction notice to "Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer" [Gynecologic Oncology Volume 115, Issue 1, October 2009, Pages 112-120].
Taylor DD; Gercel-Taylor C; Parker LP
Gynecol Oncol; 2023 Aug; 175():193. PubMed ID: 37479419
[No Abstract] [Full Text] [Related]
29. Extrauterine Undifferentiated Uterine Sarcoma Arising from Bladder Endometriosis in a Postmenopausal Woman: A Case Report.
Sim YB; Baek JK; Seo SK
J Menopausal Med; 2023 Dec; 29(3):139-142. PubMed ID: 38230598
[TBL] [Abstract][Full Text] [Related]
30. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A; Multinu F; De Vitis LA; Cosio S; Carinelli S; Aletti GD
Gynecol Oncol; 2023 Apr; 171():95-105. PubMed ID: 36842409
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract][Full Text] [Related]
32. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract][Full Text] [Related]
33. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
[TBL] [Abstract][Full Text] [Related]
34. High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001.
Ayhan A; Tunc M; Boran N; Khatib G; Gokcu M; Simsek T; Ozen OI; Toptas T; Yalcin I; Meydanli MM
Arch Gynecol Obstet; 2021 Aug; 304(2):475-483. PubMed ID: 33392719
[TBL] [Abstract][Full Text] [Related]
35. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
